Mirati Therapeutics, Inc.

MRTXNASDAQHealthcare

$58.70

$-0.10(-0.17%)

Market Cap$4.1B

P/E Ratio—

52W High$64.41

52W Low$27.3

Avg Volume1.8M

Open$58.86

Beta0.77

Overview

Mirati Therapeutics, Inc. (MRTX) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · MRTX · as of Feb 28, 2023

Latest filing snapshot

593

+175+41.87%vs prior year

Mirati Therapeutics, Inc. (MRTX) employee data is sourced from the annual SEC 10-K filing. As of 2022, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2022-12-31·Full-time · Global

Total Employees

593

Change (1Y)

+175

Growth % (1Y)

+41.87%

Revenue / Employee

$21.0K

Net Income / Employee

$-1.25M

Market Cap

$4.1B

MRTX Employee Count

2013 – 2022 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2023-02-28	2022-12-31	593	+175	+41.87%
2022-02-28	2021-12-31	418	+217	+107.96%
2021-02-25	2020-12-31	201	+90	+81.08%
2020-02-26	2019-12-31	111	+48	+76.19%
2019-02-28	2018-12-31	63	+12	+23.53%
2018-03-08	2017-12-31	51	-1	-1.92%
2017-03-09	2016-12-31	52	+5	+10.64%
2016-03-09	2015-12-31	47	+14	+42.42%
2015-03-11	2014-12-31	33	+2	+6.45%
2014-03-17	2013-12-31	31	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

MRTX

Mirati Therapeutics, Inc.YOU

Chinook Therapeutics, Inc.

Alpine Immune Sciences, Inc.

142$4.5B #6

MORF

Morphic Holding, Inc.

128$2.9B #7

CBAY

CymaBay Therapeutics, Inc.

101$3.7B

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · MRTX peer comparison

About MRTX employees

MRTX Employees · Headcount

Mirati Therapeutics, Inc. (MRTX) employee data is sourced from the annual SEC 10-K filing. As of 2022, Mirati Therapeutics, Inc. had 593 full-time employees globally. Full-time employees only. Global consolidated headcount.

Mirati Therapeutics, Inc. employs 593 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $20,971, reflecting the company's operational efficiency.

Mirati Therapeutics, Inc.'s workforce increased by 175 (41.87%) in 2022 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Mirati Therapeutics, Inc.'s revenue per employee of $20,971 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

MRTX Employees · 5 questions

As of the latest SEC 10-K filing (2022), Mirati Therapeutics, Inc. had 593 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Mirati Therapeutics, Inc. employee counthow many employees does Mirati Therapeutics, Inc. haveMRTX total employees 2022

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2023-02-28